David P Fivenson

Summary

Country: USA

Publications

  1. ncbi Treatment of generalized lichen planus with alefacept
    David P Fivenson
    Fivenson Dermatology, Ann Arbor, Mich, USA
    Arch Dermatol 142:151-2. 2006
  2. ncbi A complete and durable response to denileukin diftitox in a patient with mycosis fungoides
    Catherine D Carretero-Margolis
    Department of Dermatology, Henry Ford Health System, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI 48202-2689, USA
    J Am Acad Dermatol 48:275-6. 2003
  3. ncbi Etanercept improves psoriatic arthritis patient-reported outcomes: results from EDUCATE
    Ellen H Frankel
    Clinical Partners LLC, Cranston, Rhode Island 02910, USA
    Cutis 79:322-6. 2007

Collaborators

  • Ellen H Frankel
  • Catherine D Carretero-Margolis
  • Chiun-Fang Chiou
  • Chiun Fang Chiou
  • J Michael Woolley
  • Hong A Xia
  • Seth R Stevens
  • Bruce E Strober
  • Elaine B Yu
  • Jeffrey J Crowley

Detail Information

Publications3

  1. ncbi Treatment of generalized lichen planus with alefacept
    David P Fivenson
    Fivenson Dermatology, Ann Arbor, Mich, USA
    Arch Dermatol 142:151-2. 2006
  2. ncbi A complete and durable response to denileukin diftitox in a patient with mycosis fungoides
    Catherine D Carretero-Margolis
    Department of Dermatology, Henry Ford Health System, Henry Ford Hospital, 2799 W Grand Boulevard, Detroit, MI 48202-2689, USA
    J Am Acad Dermatol 48:275-6. 2003
    ....
  3. ncbi Etanercept improves psoriatic arthritis patient-reported outcomes: results from EDUCATE
    Ellen H Frankel
    Clinical Partners LLC, Cranston, Rhode Island 02910, USA
    Cutis 79:322-6. 2007
    ..We present data on patient-reported outcomes (PROs) from EDUCATE, which demonstrate that subjects with PsA achieved clinically meaningful improvements in both skin- and joint-related PROs after 24 weeks of treatment...